Market Shift Pushes Lilly to Abandon Construction of $325 Million Insulin Plant in Virginia

Market Shift Pushes Lilly to Abandon Construction of $325 Million Insulin Plant in Virginia

Following a strong trend within the pharmaceutical sector (reference: 2007 Pharmaceutical-Biotech Industry Forecast), the company has devised an...

Subscribe Now!

(All Fields Required)

Fill Out Form To Subscribe +

First Name

Last Name

Email Address

Username

Password

Repeat Password

Related Articles

All Members Receive the Following Resources:

Industry News Digest
Upcoming Webinars
On-Demand Webinars
The NavigatIIR Newsletter
Economic Indicators

View All Member Resources